Clinical Trials Browser

Phase 1/2 × Advanced Malignant Tumors × pembrolizumab × Clear all

NCT06877650 2026-01-29

First-in-Human Investigation of JMT108 Injection in Participants With Advanced Malignant Tumors

Phase 1/2 Recruiting

Advanced Malignant Tumors